Pharmacy

Your Article Summary

See Latest Articles

New Findings Demonstrate Potential Benefits of GATTEX(TM) (teduglutide) in Phase 3 Study of Patients with Short Bowel Syndrome
NPS Pharmaceuticals, 06/04/09

Clinical investigators presented new data from three sub-studies in patients with short bowel syndrome who received GATTEX (teduglutide) during a 24-week, placebo-controlled Phase 3 clinical trial. Results were presented at the annual Digestive Disease Week Congress taking place in Chicago.

Today in Drug Trials...keeping you current

Receive free subspecialty "5-minute updates" via email

Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial
Surgery Today, 12/14/09

Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis
Roche, 12/14/09

Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease
Clinical Drug Investigation, 12/14/09

 See all of Drug Trials

Today in Stomach/GI...keeping you current

Receive free subspecialty "5-minute updates" via email

Palliative treatment of unresectable metastatic colorectal cancer
Expert Opinion in Pharmacotherapy, 12/14/09

Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial
Surgery Today, 12/14/09

Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients
Transplant Infectious Disease, 12/11/09

 See all of Stomach/GI